Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Assessing aquitard integrity in a complex aquifer - aquitard system contaminated by chlorinated hydrocarbons.

Filippini M, Parker BL, Dinelli E, Wanner P, Chapman SW, Gargini A.

Water Res. 2020 Mar 15;171:115388. doi: 10.1016/j.watres.2019.115388. Epub 2019 Dec 14.

PMID:
31877474
2.

Identification of Degradation Pathways of Chlorohydrocarbons in Saturated Low-Permeability Sediments Using Compound-Specific Isotope Analysis.

Wanner P, Parker BL, Chapman SW, Lima G, Gilmore A, Mack EE, Aravena R.

Environ Sci Technol. 2018 Jul 3;52(13):7296-7306. doi: 10.1021/acs.est.8b01173. Epub 2018 Jun 19.

PMID:
29865795
3.

DFN-M field characterization of sandstone for a process-based site conceptual model and numerical simulations of TCE transport with degradation.

Pierce AA, Chapman SW, Zimmerman LK, Hurley JC, Aravena R, Cherry JA, Parker BL.

J Contam Hydrol. 2018 May;212:96-114. doi: 10.1016/j.jconhyd.2018.03.001. Epub 2018 Mar 3.

PMID:
29530334
4.

Quantification of Degradation of Chlorinated Hydrocarbons in Saturated Low Permeability Sediments Using Compound-Specific Isotope Analysis.

Wanner P, Parker BL, Chapman SW, Aravena R, Hunkeler D.

Environ Sci Technol. 2016 Jun 7;50(11):5622-30. doi: 10.1021/acs.est.5b06330. Epub 2016 May 18.

PMID:
27153381
5.

Testing high resolution numerical models for analysis of contaminant storage and release from low permeability zones.

Chapman SW, Parker BL, Sale TC, Doner LA.

J Contam Hydrol. 2012 Aug;136-137:106-16. doi: 10.1016/j.jconhyd.2012.04.006. Epub 2012 May 1.

PMID:
22750557
6.

Role of back diffusion and biodegradation reactions in sustaining an MTBE/TBA plume in alluvial media.

Rasa E, Chapman SW, Bekins BA, Fogg GE, Scow KM, Mackay DM.

J Contam Hydrol. 2011 Nov 1;126(3-4):235-47. doi: 10.1016/j.jconhyd.2011.08.006. Epub 2011 Aug 27.

7.

Plume persistence in fractured sedimentary rock after source zone removal.

Parker BL, Chapman SW, Cherry JA.

Ground Water. 2010 Nov-Dec;48(6):799-803. doi: 10.1111/j.1745-6584.2010.00755.x. Epub 2010 Sep 16. No abstract available.

PMID:
20849424
8.

Bacteria that masquerade as fungi: actinomycosis/nocardia.

Sullivan DC, Chapman SW.

Proc Am Thorac Soc. 2010 May;7(3):216-21. doi: 10.1513/pats.200907-077AL. Review.

PMID:
20463251
9.

The interaction of mannose binding lectin (MBL) with mannose containing glycopeptides and the resultant potential impact on invasive fungal infection.

Sealy PI, Garner B, Swiatlo E, Chapman SW, Cleary JD.

Med Mycol. 2008 Sep;46(6):531-9. doi: 10.1080/13693780801961329.

PMID:
19180724
10.

Isolation, establishment, and characterization of ex vivo equine melanoma cell cultures.

Chapman SW, Metzger N, Grest P, Feige K, von Rechenberg B, Auer JA, Hottiger MO.

In Vitro Cell Dev Biol Anim. 2009 Mar-Apr;45(3-4):152-62. doi: 10.1007/s11626-008-9156-3. Epub 2008 Dec 5.

PMID:
19057970
11.

Plume persistence caused by back diffusion from thin clay layers in a sand aquifer following TCE source-zone hydraulic isolation.

Parker BL, Chapman SW, Guilbeault MA.

J Contam Hydrol. 2008 Nov 14;102(1-2):86-104. doi: 10.1016/j.jconhyd.2008.07.003. Epub 2008 Jul 15.

PMID:
18775583
12.

Association between Histoplasma exposure and stroke.

Cleary JD, Pearson M, Oliver J, Chapman SW.

J Stroke Cerebrovasc Dis. 2008 Sep;17(5):312-9. doi: 10.1016/j.jstrokecerebrovasdis.2008.01.015.

PMID:
18755412
13.

Vomiting and diarrhea in a 51-year-old woman with splenectomy.

Muzny CA, Pearson CL, Campbell GD, Chapman SW.

Chest. 2008 Aug;134(2):438-441. doi: 10.1378/chest.07-2924. No abstract available.

PMID:
18682464
14.

In search of the holy grail of antifungal therapy.

Chapman SW, Sullivan DC, Cleary JD.

Trans Am Clin Climatol Assoc. 2008;119:197-215; discussion 215-6. Review.

15.

Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America.

Chapman SW, Dismukes WE, Proia LA, Bradsher RW, Pappas PG, Threlkeld MG, Kauffman CA; Infectious Diseases Society of America.

Clin Infect Dis. 2008 Jun 15;46(12):1801-12. doi: 10.1086/588300.

PMID:
18462107
16.

Reduced Candida glabrata susceptibility secondary to an FKS1 mutation developed during candidemia treatment.

Cleary JD, Garcia-Effron G, Chapman SW, Perlin DS.

Antimicrob Agents Chemother. 2008 Jun;52(6):2263-5. doi: 10.1128/AAC.01568-07. Epub 2008 Mar 31.

17.

Azole prophylaxis to prevent invasive fungal infections in patients with profound neutropenia.

Chapman SW.

Curr Infect Dis Rep. 2007 Nov;9(6):446-7. No abstract available.

PMID:
17999879
18.

Azole prophylaxis to prevent invasive fungal infections in patients with severe graft-versus-host disease.

Chapman SW.

Curr Infect Dis Rep. 2007 Nov;9(6):445-6. No abstract available.

PMID:
17999878
19.

Clinical practice guidelines for the management of sporotrichosis: 2007 update by the Infectious Diseases Society of America.

Kauffman CA, Bustamante B, Chapman SW, Pappas PG; Infectious Diseases Society of America.

Clin Infect Dis. 2007 Nov 15;45(10):1255-65. Epub 2007 Oct 8.

PMID:
17968818
20.

High purity amphotericin B.

Cleary JD, Chapman SW, Swiatlo E, Kramer R.

J Antimicrob Chemother. 2007 Dec;60(6):1331-40. Epub 2007 Oct 5.

PMID:
17921178
21.

Single low-dose mebendazole administered quarterly for ascaris treatment.

Cleary JD, Graham D, Lushbaugh WB, Nolan RL, Chapman SW.

Am J Med Sci. 2007 Jun;333(6):340-5.

PMID:
17570986
22.

Anidulafungin versus fluconazole for invasive candidiasis.

Reboli AC, Rotstein C, Pappas PG, Chapman SW, Kett DH, Kumar D, Betts R, Wible M, Goldstein BP, Schranz J, Krause DS, Walsh TJ; Anidulafungin Study Group.

N Engl J Med. 2007 Jun 14;356(24):2472-82.

23.

Groundwater-surface water interaction and its role on TCE groundwater plume attenuation.

Chapman SW, Parker BL, Cherry JA, Aravena R, Hunkeler D.

J Contam Hydrol. 2007 May 14;91(3-4):203-32. Epub 2006 Dec 19.

PMID:
17182152
24.

Pump-and-treat remediation of chlorinated solvent contamination at a controlled field-experiment site.

Rivett MO, Chapman SW, Allen-King RM, Feenstra S, Cherry JA.

Environ Sci Technol. 2006 Nov 1;40(21):6770-81.

PMID:
17144309
25.

Thrombocytosis during antifungal therapy of candidemia.

Saathoff AD, Elkins SL, Chapman SW, McAllister SF, Cleary JD.

Ann Pharmacother. 2005 Jul-Aug;39(7-8):1238-43. Epub 2005 May 24.

PMID:
15914515
26.

Field study of TCE diffusion profiles below DNAPL to assess aquitard integrity.

Parker BL, Cherry JA, Chapman SW.

J Contam Hydrol. 2004 Oct;74(1-4):197-230.

PMID:
15358493
27.

Comparative evaluation of the efficacy and safety of two doses of terbinafine (500 and 1000 mg day(-1)) in the treatment of cutaneous or lymphocutaneous sporotrichosis.

Chapman SW, Pappas P, Kauffmann C, Smith EB, Dietze R, Tiraboschi-Foss N, Restrepo A, Bustamante AB, Opper C, Emady-Azar S, Bakshi R.

Mycoses. 2004 Feb;47(1-2):62-8.

28.

Effects of amphotericin B and caspofungin on histamine expression.

Cleary JD, Schwartz M, Rogers PD, de Mestral J, Chapman SW.

Pharmacotherapy. 2003 Aug;23(8):966-73.

PMID:
12921242
29.

Blastomycosis.

Bradsher RW, Chapman SW, Pappas PG.

Infect Dis Clin North Am. 2003 Mar;17(1):21-40, vii. Review.

PMID:
12751259
30.

A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects.

Rex JH, Pappas PG, Karchmer AW, Sobel J, Edwards JE, Hadley S, Brass C, Vazquez JA, Chapman SW, Horowitz HW, Zervos M, McKinsey D, Lee J, Babinchak T, Bradsher RW, Cleary JD, Cohen DM, Danziger L, Goldman M, Goodman J, Hilton E, Hyslop NE, Kett DH, Lutz J, Rubin RH, Scheld WM, Schuster M, Simmons B, Stein DK, Washburn RG, Mautner L, Chu TC, Panzer H, Rosenstein RB, Booth J; National Institute of Allergy and Infectious Diseases Mycoses Study Group.

Clin Infect Dis. 2003 May 15;36(10):1221-8. Epub 2003 May 8.

PMID:
12746765
31.

Variability in polyene content and cellular toxicity among deoxycholate amphotericin B formulations.

Cleary JD, Rogers PD, Chapman SW.

Pharmacotherapy. 2003 May;23(5):572-8.

PMID:
12741430
32.

Voriconazole: a new triazole antifungal agent.

Pearson MM, Rogers PD, Cleary JD, Chapman SW.

Ann Pharmacother. 2003 Mar;37(3):420-32. Review.

PMID:
12639175
33.
34.

Necrotizing fasciitis of the upper extremity resulting from a water moccasin bite.

Angel MF, Zhang F, Jones M, Henderson J, Chapman SW.

South Med J. 2002 Sep;95(9):1090-4.

PMID:
12356121
35.

The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis.

Perfect JR, Cox GM, Lee JY, Kauffman CA, de Repentigny L, Chapman SW, Morrison VA, Pappas P, Hiemenz JW, Stevens DA; Mycoses Study Group.

Clin Infect Dis. 2001 Dec 1;33(11):1824-33. Epub 2001 Oct 22.

PMID:
11692293
37.

Intravenous itraconazole.

Slain D, Rogers PD, Cleary JD, Chapman SW.

Ann Pharmacother. 2001 Jun;35(6):720-9. Review.

PMID:
11408991
38.

Amphotericin B induces expression of genes encoding chemokines and cell adhesion molecules in the human monocytic cell line THP-1.

Rogers PD, Stiles JK, Chapman SW, Cleary JD.

J Infect Dis. 2000 Oct;182(4):1280-3. Epub 2000 Aug 28.

PMID:
10979935
39.

Practice guidelines for the management of patients with sporotrichosis. For the Mycoses Study Group. Infectious Diseases Society of America.

Kauffman CA, Hajjeh R, Chapman SW.

Clin Infect Dis. 2000 Apr;30(4):684-7. Epub 2000 Apr 20.

PMID:
10770730
40.

Practice guidelines for the management of patients with blastomycosis. Infectious Diseases Society of America.

Chapman SW, Bradsher RW Jr, Campbell GD Jr, Pappas PG, Kauffman CA.

Clin Infect Dis. 2000 Apr;30(4):679-83. Epub 2000 Apr 20.

PMID:
10770729
41.

Amphotericin B-induced interleukin-1beta expression in human monocytic cells is calcium and calmodulin dependent.

Rogers PD, Kramer RE, Chapman SW, Cleary JD.

J Infect Dis. 1999 Oct;180(4):1259-66.

PMID:
10479156
42.

Reply.

Rogers PD, Jenkins JK, Chapman SW, Cleary JD.

J Infect Dis. 1999 Oct;180(4):1410-1411. No abstract available.

PMID:
10479187
43.

Administration of crushed extended-release pentoxifylline tablets: bioavailability and adverse effects.

Cleary JD, Evans PC, Hikal AH, Chapman SW.

Am J Health Syst Pharm. 1999 Aug 1;56(15):1529-34.

PMID:
10478991
44.

Antifungal therapy during pregnancy.

King CT, Rogers PD, Cleary JD, Chapman SW.

Clin Infect Dis. 1998 Nov;27(5):1151-60. Review.

PMID:
9827262
45.

Amphotericin B activation of human genes encoding for cytokines.

Rogers PD, Jenkins JK, Chapman SW, Ndebele K, Chapman BA, Cleary JD.

J Infect Dis. 1998 Dec;178(6):1726-33.

PMID:
9815226
46.

Susceptibilities of clinical and laboratory isolates of Blastomyces dermatitidis to ketoconazole, itraconazole, and fluconazole.

Chapman SW, Rogers PD, Rinaldi MG, Sullivan DC.

Antimicrob Agents Chemother. 1998 Apr;42(4):978-80.

47.

Reliability and validity of rigid lift and pelvic leveling device method in assessing functional leg length inequality.

Gross MT, Burns CB, Chapman SW, Hudson CJ, Curtis HS, Lehmann JR, Renner JB.

J Orthop Sports Phys Ther. 1998 Apr;27(4):285-94.

PMID:
9549712
48.

Endemic blastomycosis in Mississippi: epidemiological and clinical studies.

Chapman SW, Lin AC, Hendricks KA, Nolan RL, Currier MM, Morris KR, Turner HR.

Semin Respir Infect. 1997 Sep;12(3):219-28.

PMID:
9313293
49.

Treatment of blastomycosis with higher doses of fluconazole. The National Institute of Allergy and Infectious Diseases Mycoses Study Group.

Pappas PG, Bradsher RW, Kauffman CA, Cloud GA, Thomas CJ, Campbell GD Jr, Chapman SW, Newman C, Dismukes WE.

Clin Infect Dis. 1997 Aug;25(2):200-5.

PMID:
9332510
50.

Amphotericin B enzyme-linked immunoassay for clinical use: comparison with bioassay and HPLC.

Cleary JD, Chapman SW, Hardin TC, Rinaldi MG, Spencer JL, Deng J, Pennick GJ, Lobb CJ.

Ann Pharmacother. 1997 Jan;31(1):39-44.

PMID:
8997463

Supplemental Content

Loading ...
Support Center